PPLPHARMA.BO

Piramal Pharma Limited PPLPHARMA.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PPLPHARMA.BO PEL.NS JBCHEPHARM.BO JBCHEPHARM.NS ASTRAZEN.BO ASTRAZEN.NS AJANTPHARM.BO AJANTPHARM.NS ERIS.NS ERIS.BO
6M -7.94 % 9.10 % 5.78 % 5.46 % 3.68 % 3.84 % -13.46 % -13.46 % 4.17 % 4.22 %
YTD -21.60 % 2.70 % -9.31 % -9.65 % 28.94 % 29.41 % -19.70 % -19.35 % 18.31 % 18.30 %
1Y -21.06 % 9.61 % -10.17 % -10.56 % 29.76 % 30.14 % -18.88 % -18.72 % 22.68 % 22.84 %
3Y 24.47 % 33.43 % 72.18 % 71.40 % 201.31 % 201.19 % 94.20 % 94.47 % 114.14 % 113.66 %
5Y 8.08 % 55.43 % 240.82 % 68.43 % 112.94 % 113.00 % 130.95 % 129.31 % 215.95 % 215.89 %
10Y 8.08 % 114.64 % 1 047.66 % 470.39 % 663.61 % 668.98 % 131.69 % 131.58 % 161.85 % 162.07 %
From the beginning 8.08 % 4 306.90 % 83 375.49 % 7 336.02 % 15 920.69 % 31 253.54 % 14 968.75 % 15 320.82 % 161.85 % 162.07 %

Dividend

Piramal Pharma Limited

Piramal Enterprises Limited

J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited

AstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited

Ajanta Pharma Limited

Ajanta Pharma Limited

Eris Lifesciences Limited

Eris Lifesciences Limited